Clinical utility of comprehensive circulating tumor DNA genotyping compared with standard of care tissue testing in patients with newly diagnosed metastatic colorectal cancer

Autor: Benavides, M., Alcaide-Garcia, J., Torres, E., Gil-Calle, S., Sevilla, I., Wolman, R., Durán, G., Álvarez, M., Reyna-Fortes, C., Ales, I., Pereda, T., Robles, M., Kushnir, M., Odegaard, J., Faull, I., Alba, E.

Publikováno v: In ESMO Open June 2022 7(3)

Nab -Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer.

Autor: Carrato A; Department of Medical Oncology, Alcalá University, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Ramon y Cajal University Hospital, Madrid.; Pancreatic Cancer Europe, Brussels., Pazo-Cid R; Department of Medical Oncology, Aragon Institute of Biomedical Research, Miguel Servet University Hospital, Zaragoza, Spain., Macarulla T; Vall d'Hebrón Institute of Oncology, Vall d'Hebrón University Hospital, Barcelona., Gallego J; Department of Medical Oncology, Elche University Hospital, Alicante, Spain., Jiménez-Fonseca P; Department of Medical Oncology, Asturias Central University Hospital, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain., Rivera F; Department of Medical Oncology, Marques de Valdecilla University Hospital, Instituto de Investigación Valdecilla (IDIVAL), Santander, Spain., Cano MT; Department of Medical Oncology, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba University, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Reina Sofia University Hospital, Cordoba, Spain., Rodriguez-Garrote M; Department of Medical Oncology, University, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Ramon y Cajal University Hospital, Madrid., Pericay C; Department of Medical Oncology, Sabadell University Hospital, Parc Tauli, Sabadell, Spain., Alés I; Unidad de Gestión Clínica Intercentros (UGCI) Medical Oncology, University Regional and Virgen Victoria Hospital, Instituto de Investigación Biomédica de Málaga (IBIMA), Malaga, Spain., Layos L; Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona Applied Research Group in Oncology (B-ARGO), Germans Trias i Pujol University Hospital, Badalona, Spain., Graña B; Department of Medical Oncology, A Coruña University Hospital, Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, Spain., Iranzo V; Department of Medical Oncology, University General Hospital Valencia, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Valencia University, Valencia, Spain., Gallego I; Department of Medical Oncology, Virgen del Rocio University Hospital, Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain., Garcia-Carbonero R; Department of Medical Oncology, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), Universidad Complutense Madrid (UCM), Madrid., de Mena IR; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD), Madrid., Guillén-Ponce C; Department of Medical Oncology, Ramon y Cajal University Hospital, Madrid., Aranda E; Department of Medical Oncology, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba University, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Reina Sofia University Hospital, Cordoba, Spain.

Publikováno v: NEJM evidence [NEJM Evid] 2024 Feb; Vol. 3 (2), pp. EVIDoa2300144. Date of Electronic Publication: 2024 Jan 23.

Unveiling the Promise: Navigating Clinical Trials 1978–2024 for PDAC.

Autor: Dominguez, Angel A.¹ (AUTHOR) domingueza6@livemail.uthscsa.edu, Perz, Matthew T.¹ (AUTHOR) perzm@livemail.uthscsa.edu, Xu, Yi¹ (AUTHOR) xuy4@uthscsa.edu, Cedillo, Leonor G.¹ (AUTHOR) leocedill@gmail.com, Huang, Orry D.¹ (AUTHOR) orry.huang@utexas.edu, McIntyre, Caitlin A.² (AUTHOR) mcintyrec1@uthscsa.edu, Vudatha, Vignesh³ (AUTHOR) vignesh.vudatha@vcuhealth.org, Trevino, Jose G.³ (AUTHOR) jose.trevino@vcuhealth.org, Liu, Jun¹ (AUTHOR) liuj8@uthscsa.edu, Wang, Pei¹ (AUTHOR) wangp3@uthscsa.edu

Publikováno v: Cancers. Nov2024, Vol. 16 Issue 21, p3564. 35p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

623PD - A phase I and randomized phase II trial to evaluate the efficacy and safety of nab-paclitaxel (nab-P) in combination with gemcitabine (G) for the treatment of patients with ECOG 2 advanced pancreatic cancer (PDAC)

Autor: Hidalgo, M., Pazo-Cid, R., Guillen-Ponce, C., López, R., Vera, R., Reboredo, M., Muñoz, A., Martinez de Castro, E., Díaz Beveridge, R., La Casta, A., Martin-Valades, J.I., Cubillo, A., Martínez-Galán, J., Ales, I., Sastre, J., Macarulla Mercade, T.

Publikováno v: In Annals of Oncology September 2017 28 Supplement 5:v212-v212